» Articles » PMID: 20305094

Managing Chromoblastomycosis

Overview
Journal Trop Doct
Specialty Tropical Medicine
Date 2010 Mar 23
PMID 20305094
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Chromoblastomycosis is a subcutaneous fungal infection caused by the traumatic inoculation of the skin with pigmented saprophytic moulds. Although infection is rarely fatal, it is characteristically chronic and can be complicated by lymphatic damage and malignant transformation. Despite a variety of treatment modalities, which are often combined and include long courses of antifungals, surgical excision and destructive physical therapies, it remains one of the most difficult deep mycotic infections to eradicate.

Citing Articles

Molecular Characteristics of Regional Chromoblastomycosis in Guangdong, China: Epidemiological, Clinical, Antifungal Susceptibility, and Serum Cytokine Profiles of 45 Cases.

Liu H, Sun J, Li M, Cai W, Chen Y, Liu Y Front Cell Infect Microbiol. 2022; 12:810604.

PMID: 35252030 PMC: 8894709. DOI: 10.3389/fcimb.2022.810604.


A case of mycetoma-like chromoblastomycosis in Qatar.

Ali G, Goravey W, Taj-Aldeen S, Petkar M, Al-Bozom I, Hadi H IDCases. 2020; 21:e00853.

PMID: 32528848 PMC: 7283144. DOI: 10.1016/j.idcr.2020.e00853.


Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.

Coelho R, Brito-Santos F, Figueiredo-Carvalho M, Silva J, Gutierrez-Galhardo M, do Valle A PLoS Negl Trop Dis. 2018; 12(7):e0006675.

PMID: 30048450 PMC: 6080783. DOI: 10.1371/journal.pntd.0006675.


Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-γ production.

Dong B, Tong Z, Li R, Chen S, Liu W, Liu W PLoS Negl Trop Dis. 2018; 12(2):e0006237.

PMID: 29481557 PMC: 5843349. DOI: 10.1371/journal.pntd.0006237.


Chromoblastomycosis: tissue modifications during itraconazole treatment.

Purim K, Calvo Peretti M, Neto J, Olandoski M An Bras Dermatol. 2017; 92(4):478-483.

PMID: 28954095 PMC: 5595593. DOI: 10.1590/abd1806-4841.20175466.